These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6297023)

  • 1. [Treatment of menopausal hot flushes with a nonhormonal medication, veralipride].
    Marzolf G; Eberst B; Aerts A; Lecornu C; Mark J; Gandar R
    Sem Hop; 1982 Nov; 58(41):2382-4. PubMed ID: 6297023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride].
    Wesel S; Bosuma WB
    Sem Hop; 1983 Mar; 59(9):596-9. PubMed ID: 6304907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushes.
    Wesel S; Bourguignon RP; Bosuma WB
    Curr Med Res Opin; 1984; 8(10):696-700. PubMed ID: 6327190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and clinical and biological tolerability of the long-term administration of veralipride. Apropos of 74 cases].
    Dargent D; Dumont M; Malinas Y
    Sem Hop; 1983 Nov; 59(40):2778-80. PubMed ID: 6316535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].
    Renaud R; Macler J
    Sem Hop; 1981 Feb 18-25; 57(7-8):353-5. PubMed ID: 6261369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical trial of veralipride in menopausal complaints (author's transl)].
    Lefevre J
    Sem Hop; 1982 Feb; 58(7):411-3. PubMed ID: 6280313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)].
    Quereux C; Ezes H; Deltour G; Decaux J; Dorangeon P; Wahl P
    Sem Hop; 1980 Oct; 56(37-38):1453-9. PubMed ID: 6254160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intractable menopausal disorders cured by veralipride (author's transl)].
    Angeli S; Fougère P
    Sem Hop; 1982 Jan; 58(2):111-2. PubMed ID: 6276994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
    De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerance of veralipride in the treatment of flushing in the menopause. A multicenter study].
    Boukobza G
    Rev Fr Gynecol Obstet; 1986 Sep; 81(8):413-7. PubMed ID: 3532280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
    Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
    Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
    David A; Don R; Tajchner G; Weissglas L
    Am J Obstet Gynecol; 1988 May; 158(5):1107-15. PubMed ID: 2967034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of veralipride.
    De Leo V; Morgante G; Musacchio MC; Faldini E; Delia A; Petraglia F
    Expert Opin Drug Saf; 2006 Sep; 5(5):695-701. PubMed ID: 16907659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
    Carretti N; Florio P; Reis FM; Comai S; Bertazzo A; Petraglia F
    Climacteric; 2010 Apr; 13(2):141-6. PubMed ID: 20082603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.